SEC Form D · filed March 15, 2017
Immunomic Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
William G. Hearl · ROCKVILLE, MDExec · DirectorRonald P. Thiboutot · ROCKVILLE, MDDirectorJames W. Wishart · ROCKVILLE, MDDirectorMichael D. Lack · ROCKVILLE, MDDirectorC. E. Winzer · ROCKVILLE, MDExec · DirectorWilliam B. Mcdonald · ROCKVILLE, MDDirectorNoah Gottdiener · New York, NYDirectorNic Volpi · New York, NYDirectorEdward W. Forman · New York, NYExec · DirectorPatrick Puzzuoli · New York, NYDirectorJacob Silverman · New York, NYDirectorNancy Lewis · New York, NYExec · DirectorHanieh Sadathendi · Los Angeles, CAExec · DirectorLeise N. Rosman · Phoenix, AZDirectorTrevor N. Pratte · Phoenix, AZDirectorKris N. Krane · Phoenix, AZExec · DirectorKarl N. Chowscano · Phoenix, AZDirectorEric A. Naison-Phillips · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗